Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system

Journal of Molecular Biology

Volumn 293, Issue 1, 1999, Pages 93-106

  Rester, Ulrich ^a   Bode, Wolfram ^a   Moser, Matthias ^b   Parry, Marina A A ^a   Huber, Robert ^a   Auerswald, Ennes ^b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bdellastasin; Crystal structure; Microplasmin; Proteinase inhibition; Trypsin

Indexed keywords

ANTIPLASMIN; ANTISTASIN; BDELLASTASIN; LYSINE; PLASMIN; PROTEINASE INHIBITOR; SERINE PROTEINASE; TRYPSIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOT; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CRYSTAL STRUCTURE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEINASE INHIBITION;

BOVINAE; HIRUDINIDA; HIRUDO MEDICINALIS; SUIDAE;

EID: 0033569346     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3162     Document Type: Article

References (57)

1. Barton G. J. ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng. 6:1993;37-40.
2. Bartunik H. D., Summers L. J., Bartsch H. H. Crystal structure of bovine beta-trypsin at 1.5 Å resolution in a crystal form with low molecular packing density. Active site geometry, ion pairs and solvent structure. J. Mol. Biol. 210:1989;813-828.
3. Blankenship D. T., Brankamp R. G., Manley G. D., Cardin A. D. Amino acid sequence of ghilanten: anticoagulant-antimetastatic principle of the South American leech, Haementeria ghilianii. Biochem. Biophys. Res. Commun. 166:1990;1384-1389.
4. Bock P. E., Day D. E., Verhamme I. M., Bernardo M. M., Olson S. T., Shore J. D. Analogs of human plasminogen that are labeled with fluorescence probes at the catalytic site of the zymogen. Preparation, characterization, and interaction with streptokinase. J. Biol. Chem. 271:1996;1072-1080.
5. Bode W., Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur. J. Biochem. 204:1992;433-451.
6. Brandstetter H., Kühne A., Bode W., Huber R., von der Saal W., Wirthensohn K., Engh R. A. X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition. J. Biol. Chem. 271:1996;29988-29992.
7. Brankamp R. G., Blankenship D. T., Sunkara P. S., Cardin A. D. Ghilantens: anticoagulant-antimetastatic proteins from the South American leech, Haementeria ghilianii. Lab. Clin. Med. 115:1990;89-97.
8. Brünger A. T. X-PLOR Version 3.1. A System for X-ray Crystallography and NMR. 1992a;Yale University Press, New Haven.
9. Brünger A. T. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355:1992b;472-475.
10. Brünger A. T., Adams P. D., Clore G. M., Delano W. L., Gros P., Grosse-Kunstleve R. W., Jiang J.-S., Kuszewski J., Nilges N., Pannu N. S., Read R. J., Rice L. M., Simonson T., Warren G. L. Crystallography and NMR systems (CNS): a new software system for macromolecular structure determination. Acta Crystallog. sect. D. 54:1998;905-921.
11. CCP4. The CCP4 suite. Acta Crystallog. sect. D. 50:1994;760-763.
12. Chandler W. L. The human fibrinolytic system. Crit. Rev. Oncol. Hematol. 24:1996;27-45.
13. Chapman H. A. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9:1997;714-724.
14. Condra C., Nutt E., Petroski C. J., Simpson E., Friedman P. A., Jacobs J. W. Isolation and structural characterization of a potent inhibitor of coagulation factor Xa from the leech Haementeria ghilianii. Thromb. Haemostasis. 61:1989;437-441.
15. Danö K., Andreasen P. A., Grondahl-Hansen J., Kristensen P., Nielsen L. S., Skriver L. Plasminogen activators, tissue degradation, and cancer. Advan. Cancer Res. 44:1985;139-266.
16. Di Marco S., Priestle J. P. Structure of the complex of leech-derived tryptase inhibitor (LDTI) with trypsin and modeling of the LDTI-tryptase system. Structure. 5:1997;1465-1474.
17. Electricwala A., von Sicard N. A. E., Sawyer R. T., Atkinson T. Biochemical characterisation of a pancreatic elastase inhibitor from the leech Hirudinaria manillensis. J. Enzyme Inhib. 6:1993;293-302.
18. Engh R. A., Huber R. Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallog. sect. A. 47:1991;392-400.
19. Esnouf R. M. BOBSCRIPT. J. Mol. Graph. 15:1997;132-134.
20. Fritz H., Krejci K. Trypsin-plasmin inhibitors (bdellins) from leeches. Methods Enzymol. 45:1976;797-806.
21. Fritz H., Gebhardt M., Meister R., Fink E. Trypsin-plasmin inhibitors from leeches - isolation, amino acid composition, inhibitory characteristics. Fritz H., Tschesche H. Proceedings of the International Research Conference on Proteinase Inhibitors. 1971;271-280 Walter de Gruyter, Berlin.
22. Geiger T., Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 262:1987;785-794.
23. Han J. H., Law S. W., Keller P. M., Kniskern P. J., Silberklang M., Tung J. S., Gasic T. B., Gasic G. J., Friedman P. A., Ellis R. W. Cloning and expression of cDNA encoding antistasin, a leech-derived protein having anti-coagulant and anti-metastatic properties. Gene. 75:1989;47-57.
24. Jackson R. M., Gabb H. A., Sternberg M. J. Rapid refinement of protein interfaces incorporating solvation: application to the docking problem. J. Mol. Biol. 276:1998;265-285.
25. Jones T. A., Zou J.-Y., Cowan S. W., Kjeldgaard M. Improved methods for building proteins in electron density maps and location of errors in these models. Acta Crystallog. sect. A. 47:1991;110-119.
26. Jordan S. P., Mao S. S., Lewis S. D., Shafer J. A. Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide. Biochemistry. 31:1992;5374-5380.
27. Jung H. I., Kim S. I., Ha K. S., Joe C. O., Kang K. W. Isolation and characterization of guamerin, a new human leukocyte elastase inhibitor from Hirudo nipponia. J. Biol. Chem. 270:1995;13879-13884.
28. Kim D. R., Hong S. J., Ha K. S., Joe C. O., Kang K. W. A cysteine-rich serine protease inhibitor (Guamerin II) from the non-blood sucking leech Whitmania edentula: biochemical characterization and amino acid sequence analysis. J. Enzyme Inhib. 10:1996;81-91.
29. Kleywegt G. J., Jones T. A. Halloween . . . masks and bones. Bailey S., Hubbard R., Waller D. From First Map to Final Model. 1994;59-66 SERC Daresbury Laboratory, Warrington.
30. Kraulis P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
31. Lapatto R., Krengel U., Schreuder H. A., Arkema A., de Boer B., Kalk K. H., Hol W. G., Grootenhuis P. D., Mulders J. W., Dijkema R., Theunissen H. J., Dijkstra B. W. X-ray structure of antistasin at 1.9 Å resolution and its modelled complex with blood coagulation factor Xa. EMBO J. 16:1997;5151-5161.
32. Laskowski R. A., MacArthur M. W., Mass S. D., Thornton J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-291.
33. Leslie A. G. W. Mosflm User Guide, Mosflm Version 5.20. 1994;MRC Laboratory of Molecular Biology, Cambridge.
34. Lottenberg R. A novel approach to explore the role of plasminogen in bacterial pathogenesis. Trends Microbiol. 5:1997;466-468.
35. Madison E. L. Probing structure function relationships of tissue-type plasminogen activator by site specific mutagenesis. Fibrinolysis. 8:1994;221-236.
36. Marquart M., Walter J., Deisenhofer J., Bode W., Huber R. The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors. Acta Crystallog. sect. B. 39:1983;480-490.
37. Mayer M. Biochemical and biological aspects of the plasminogen activation system. Clin. Biochem. 23:1990;197-211.
38. McPherson A. Editor of Preparation and Analysis of Protein Crystals. 1989;Krieger Publishing Co. Malabar.
39. Merritt E. A., Murphy M. E. P. Rater3D version 2.0. a program for photorealistic molecular graphics. Acta Crystallog. sect. D. 50:1994;869-873.
40. Mitchell J. B. O., Nandl C. L., Ali S., McDonald I. K., Thornton J. M., Price S. L., Singh J. Amino/aromatic interactions. Nature. 366:1993;413.
41. Mittl P. R., Di Marco S., Fendrich G., Pohlig G., Heim J., Sommerhoff C., Fritz H., Priestle J. P., Grütter M. G. A new structural class of serine protease inhibitors revealed by the structure of the hirustasin-kallikrein complex. Structure. 5:1997;253-264.
42. Moser M., Auerswald E., Mentele R., Eckerskorn C., Fritz H., Fink E. Bdellastasin, a serine protease inhibitor of the antistasin family from the medical leech (Hirudo medicinalis) - primary structure, expression in yeast, and characterisation of native and recombinant inhibitor. Eur. J. Biochem. 253:1998;212-220.
43. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
44. Nicholls A., Bharadwaj R., Honig B. GRASP - graphical representation and analysis of surface properties. Biophys. J. 64:1993;A166.
45. Nutt E., Gasic T., Rodkey J., Gasic G. J., Jacobs J. W., Friedman P. A., Simpson E. The amino acid sequence of antistasin. A potent inhibitor of factor Xa reveals a repeated internal structure. J. Biol. Chem. 263:1988;10162-10167.
46. Parry M. A., Fernandez-Catalan C., Bergner A., Huber R., Hopfner K. P., Schlott B., Guhrs K. H., Bode W. The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Nature Struct. Biol. 5:1998;917-923.
47. Rodham D. A., Suzuki S., Suenram R. D., Lovas F. J., Dasgupta S., Goddard W. A. III, Blake G. A. Hydrogen bonding in the benzene-ammonia dimer. Nature. 362:1993;735-737.
48. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27:1967;157-162.
49. Söllner C., Mentele R., Eckerskorn C., Fritz H., Sommerhoff C. P. Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leechHirudo medicinalis. Eur. J. Biochem. 219:1994;937-943.
50. Sreenivasan U., Axelsen P. H. Buried water in homologous serine proteases. Biochemistry. 31:1992;12785-12791.
51. Stubbs M. T., Morenweiser R., Stürzebecher J., Bauer M., Bode W., Huber R., Piechottka G. P., Matschiner G., Sommerhoff C. P., Fritz H., Auerswald E. A. The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition. J. Biol. Chem. 272:1997;19931-19937.
52. Tong L., Rossmann M. G. The locked rotation function. Acta Crystallog. sect. A. 46:1990;783-792.
53. Turk D. Weiterentwicklung eines Programmes für Molekülgrafik und Elektronendichte-Manipulation und seine Anwendung auf Verschiedene Protein-Strukturaufklärungen, PhD thesis. 1992;Technische Universität München, München.
54. Usón I., Sheldrick G. M., La Fortelle E., Bricogne G., Di Marco S., Priestle J. P., Grütter M. G., Mittl P. R. E. The 1.2 Å crystal structure of hirustasin reveals the intrinsic flexibility of a amily of highly disulphide-bridged inhibitors. Structure. 7:1999;55-63.
55. Vassalli J. D., Sappino A. P., Belin D. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1991;1067-1072.
56. Wang X., Lin X., Loy J. A., Tang J., Zhang X. C. Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science. 281:1998;1662-1665.
57. Wei A., Alexander R. S., Duke J., Ross H., Rosenfeld S. A., Chang C. H. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa. J. Mol. Biol. 283:1998;147-154.